Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic

Abstract excerpt

Genome editing using clustered regularly interspersed short palindromic repeats (CRISPR) and CRISPR-associated proteins offers the potential to facilitate safe and effective treatment of genetic diseases refractory to other types of intervention. Here, we identify some of the major challenges for clinicians, regulators, and human research ethics committees in the clinical translation of CRISPR-mediated somatic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomedical Ethics and Regulation
• Share to CRISPR and Genetic Engineering
• Share to Pluripotent Stem Cells Research